We are pioneering the next-generation biochip for research, diagnostics, and personalized medicine. Our biochip platform offers ultra-high feature density, modularity, and adaptability to integrate and enhance sequencing, transcriptomics, and proteomics applications. To realize this vision, SPRIND - Germany's Federal Agency for Disruptive Innovation funds Nanogami as one of six projects for the next five years.
| Employees | 13 (13 on RocketReach) |
| Founded | 2022 |
| Industry | Biotechnology Research |
Looking for a particular Nanogami employee's phone or email?
Katarina Irić is the VP, Sequencing and Omics (Product and Commercial Strategy) of Nanogami.
13 people are employed at Nanogami.